GlassScriptPhysician profile
Rodney A Engel
NPI 1659351187
$1,022.15
in general payments reported to CMS, 2019-2025
17 companies · $240 in 2025
The $240 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.74 · 2021: $5.85 · 2022: $73.47 · 2023: $216 · 2024: $471 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $927.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $157.46 | 2023-2024 | |
| Janssen Biotech, INC. | $136.62 | 2022-2025 | Tremfya, Erleada, Stelara |
| Takeda Pharmaceuticals U.S.A., INC. | $104.10 | 2024-2025 | Entyvio |
| Genzyme Corporation | $98.45 | 2022-2024 | |
| Pfizer INC. | $87.92 | 2023-2025 | |
| Boston Scientific Corporation | $79.88 | 2021-2024 | Captivator II |
| Lilly USA, LLC | $55.74 | 2025 | Omvoh |
| Lucid Diagnostics INC. | $44.20 | 2024 | |
| Medtronic, INC. | $39.46 | 2024-2025 | Pillcam, Interstim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.64 | 2019-2025 | Xifaxan |
| Merck Sharp & Dohme LLC | $34.11 | 2023-2024 | Dificid |
| Organon LLC | $30.81 | 2024 | |
| Gilead Sciences, INC. | $27.16 | 2025 | Livdelzi |
| Intercept Pharmaceuticals, INC. | $27.06 | 2024 | |
| Celgene Corporation | $24.52 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $21.30 | 2024 | Iqirvo |
| Digestive Care, INC. | $16.72 | 2023 | Pertzye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodney Engel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.